Response to: McBride A,Campbell K,Bikkina M,et al. Cost-efficiency analyses for the US of biosimilar filgrastim-sndz,reference filgrastim,pegfilgrastim, and pegfilgrastim with on-body injector in the prophylaxis of chemotherapy-induced (febrile) neutropenia. J Med Econ 2017;20:1083–93 期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

Response to: McBride A,Campbell K,Bikkina M,et al. Cost-efficiency analyses for the US of biosimilar filgrastim-sndz,reference filgrastim,pegfilgrastim, and pegfilgrastim with on-body injector in the prophylaxis of chemotherapy-induced (febrile) neutropenia. J Med Econ 2017;20:1083–93

摘要：